Literature DB >> 24425693

Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia.

Matteo G Della Porta1, Cristina Picone, Annamaria Tenore, Norio Yokose, Luca Malcovati, Mario Cazzola, Kiyoyuki Ogata.   

Abstract

Entities:  

Keywords:  flow cytometric score; immunophenotyping; low-grade MDS; marrow dysplasia; prognostic

Mesh：

Year:  2014        PMID： 24425693      PMCID： PMC4007946          DOI： 10.3324/haematol.2013.097188

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.

Authors:  T M Westers; R Ireland; W Kern; C Alhan; J S Balleisen; P Bettelheim; K Burbury; M Cullen; J A Cutler; M G Della Porta; A M Dräger; J Feuillard; P Font; U Germing; D Haase; U Johansson; S Kordasti; M R Loken; L Malcovati; J G te Marvelde; S Matarraz; T Milne; B Moshaver; G J Mufti; K Ogata; A Orfao; A Porwit; K Psarra; S J Richards; D Subirá; V Tindell; T Vallespi; P Valent; V H J van der Velden; T M de Witte; D A Wells; F Zettl; M C Béné; A A van de Loosdrecht
Journal:  Leukemia       Date:  2012-02-06       Impact factor: 11.528

2.  Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.

Authors:  Matteo G Della Porta; Cristina Picone; Cristiana Pascutto; Luca Malcovati; Hideto Tamura; Hiroshi Handa; Magdalena Czader; Sylvie Freeman; Paresh Vyas; Anna Porwit; Leonie Saft; Theresia M Westers; Canan Alhan; Claudia Cali; Arjan A van de Loosdrecht; Kiyoyuki Ogata
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

4.  Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Authors:  Luca Malcovati; Matteo Giovanni Della Porta; Cristiana Pascutto; Rosangela Invernizzi; Marina Boni; Erica Travaglino; Francesco Passamonti; Luca Arcaini; Margherita Maffioli; Paolo Bernasconi; Mario Lazzarino; Mario Cazzola
Journal:  J Clin Oncol       Date:  2005-09-26       Impact factor: 44.544

Review 5.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

6.  Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.

Authors:  S Mathis; N Chapuis; C Debord; A Rouquette; I Radford-Weiss; S Park; F Dreyfus; C Lacombe; M C Béné; O Kosmider; M Fontenay; V Bardet
Journal:  Leukemia       Date:  2013-06-14       Impact factor: 11.528

7.  Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.

Authors:  Arjan A van de Loosdrecht; Theresia M Westers; August H Westra; Angelika M Dräger; Vincent H J van der Velden; Gert J Ossenkoppele
Journal:  Blood       Date:  2007-10-30       Impact factor: 22.113

8.  Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.

Authors:  Kiyoyuki Ogata; Matteo G Della Porta; Luca Malcovati; Cristina Picone; Norio Yokose; Akira Matsuda; Taishi Yamashita; Hideto Tamura; Junichi Tsukada; Kazuo Dan
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

9.  Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.

Authors:  M G Della Porta; L Malcovati; R Invernizzi; E Travaglino; C Pascutto; M Maffioli; A Gallì; S Boggi; D Pietra; L Vanelli; C Marseglia; S Levi; P Arosio; M Lazzarino; M Cazzola
Journal:  Leukemia       Date:  2006-04       Impact factor: 11.528
  9 in total
  3 in total

Review 1.  Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?

Authors:  Anna Porwit
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

Review 2.  MDS prognostic scoring systems – past, present, and future.

Authors:  Brian A Jonas; Peter L Greenberg
Journal:  Best Pract Res Clin Haematol       Date:  2014-11-11       Impact factor: 3.020

3.  The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system.

Authors:  C Alhan; T M Westers; E M P Cremers; C Cali; B I Witte; G J Ossenkoppele; A A van de Loosdrecht
Journal:  Leukemia       Date:  2015-10-27       Impact factor: 11.528
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.